Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations sections are consolidated under a single 'Locations' heading with updated states/countries; the HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.3.1; this is a minor site maintenance update and does not alter study details or how to use the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedPublications in PubMed section now include an explicit note that entries are automatically filled and may not be directly related to the study; the revision tag updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe funding-lapse notice is removed from the page. The study details and other information remain unchanged.SummaryDifference0.2%

- Check63 days agoChange DetectedTwo new update timestamps were added (2025-10-24 and 2025-10-27) and earlier timestamps (2025-10-21 and 2025-10-22) were removed on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedStudy Record Dates now display 'Last Update Posted (Estimated)' instead of the previous 'Last Update Posted'; the old entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.